Handelsbanken Fonder’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-120,502
Closed -$360K 1573
2023
Q2
$360K Hold
120,502
﹤0.01% 1248
2023
Q1
$417K Hold
120,502
﹤0.01% 1092
2022
Q4
$504K Hold
120,502
﹤0.01% 954
2022
Q3
$483K Sell
120,502
-105,000
-47% -$797K ﹤0.01% 987
2022
Q2
$2.55M Hold
225,502
0.02% 501
2022
Q1
$3.66M Sell
225,502
-30,000
-12% -$769K 0.02% 489
2021
Q4
$12.1M Hold
255,502
0.06% 301
2021
Q3
$18.5M Buy
255,502
+35,000
+16% +$2.53M 0.1% 214
2021
Q2
$18.5M Sell
220,502
-7,000
-3% -$462K 0.1% 224
2021
Q1
$11M Buy
227,502
+122,502
+117% +$6.65M 0.06% 277
2020
Q4
$4.95M Buy
+105,000
New +$4.13M 0.03% 410

Other funds holding NBP

Handelsbanken Fonder's NBP Position: Q3 2023 in Review

Handelsbanken Fonder sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2023, closing a stake of 120,502 shares — an estimated $360K sold.

Handelsbanken Fonder first reported a position in NBP in Q4 2020 and held it in 11 quarters. The position peaked at $18.5M in Q3 2021. 47 funds tracked by Wall St. Rank hold NBP as of Q3 2023.

  • Handelsbanken Fonder reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q3 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 120,502 NovaBridge Biosciences American Depositary Shares shares in Q3 2023, an estimated $360K.
  • Handelsbanken Fonder first reported a position in NovaBridge Biosciences American Depositary Shares in Q4 2020 and held it in 11 quarters.
  • Handelsbanken Fonder's NovaBridge Biosciences American Depositary Shares position peaked at $18.5M in Q3 2021.
  • 47 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2023.

Based on Handelsbanken Fonder's 13F filing for Q3 2023, filed 19 Oct 2023.